Clinical Trials Directory

Trials / Completed

CompletedNCT06872814

Vaccine Hesitancy in Patients with Solid Tumors: a Cross-sectional Single-center Survey

Status
Completed
Phase
Study type
Observational
Enrollment
309 (actual)
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cancer patients have a well-known and higher risk of vaccine-preventable disease (VPD) than the general population. VPD can cause serious complications due to compromised immune system, malnutrition and the same oncology treatments and represent a severe financial burden with a delay in treating the underlying cancer The main purpose of this survey is to analyse the perception of cancer patients on the topic vaccines and vaccine-preventable diseases, the acceptability of vaccines and the evaluation of the determining factors associated with the choice of the patient to be vaccinated or not. This information will be used to improve the management of these issues.

Conditions

Timeline

Start date
2024-05-31
Primary completion
2024-08-26
Completion
2024-08-26
First posted
2025-03-12
Last updated
2025-03-17

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06872814. Inclusion in this directory is not an endorsement.

Vaccine Hesitancy in Patients with Solid Tumors: a Cross-sectional Single-center Survey (NCT06872814) · Clinical Trials Directory